Outcome of the Board Meeting held on November 05, 2026, and Submission of Unaudited Financial Results for the quarter/half year ended September 30, 2026

Registered Office: “THIRUMALAI HOUSE”, Plot No. 101-102, Road No. 29, Sion (East), Mumbai – 400 022, India PHONE: +91 – 22– 43686200 FAX +91 – 22 – 24011699 E- MAIL: thirumalai@thirumalaichemicals.com Website: www.thirumalaichemicals.com (AN ISO 9001, 14001, 50001/ HACCP & FSSC 22000 CERTIFIED COMPANY) CIN: L24100MH1972PLC016149 TCL/SE053/2026-27 November 05, 2026 The National Stock Exchange of India BSE Limited Limited Department of Corporate Services Listing Department Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex Dalal Street Bandra (East) Mumbai 400 001 Mumbai 400 051 Scrip code: 500412 Scrip code: TIRUMALCHM Dear Sir/ Madam, Sub.: Outcome of the Board Meeting and Disclosures under Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR') In compliance with the provisions of Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we wish to inform you that the Board of Directors of the Company at its meeting held on Thursday, November 05, 2026, (i.e., today) have inter-alia considered and approved the following: 1. Financials Results Un-audited Financial Results (Standalone & Consolidated) for the quarter / half year ended September 30, 2026. The copies of aforesaid Financial Results along with the Limited Review Reports from the Statutory Auditors of the Company are enclosed herewith as Annexure A. 2. Reclassification of Promoters under Regulation 31A(8)(b) of SEBI LODR. This has reference to our letter no. TCL/SE050/2026-27 dated October 27, 2026, we hereby inform you that the Board of Directors at its meeting held today i.e., on November 05, 2026, has considered the request received from Mr Narayan Santhanam and Mrs Deepa Ajay who are part of our promoter group, seeking re-classification of their status as 'public', pursuant to Regulation 31A of SEBI (LODR) Regulations, 2015 and approved its submission to the Stock Exchanges for seeking approval. We enclose herewith extracts from the resolution passed at the Board meeting held today, i.e., on November 05, 2026 as Annexure B. Registered Office: “THIRUMALAI HOUSE”, Plot No. 101-102, Road No. 29, Sion (East), Mumbai – 400 022, India PHONE: +91 – 22– 43686200 FAX +91 – 22 – 24011699 E-MAIL: thirumalai@thirumalaichemicals.com Website: www.thirumalaichemicals.com (AN ISO 9001, 14001, 50001/ HACCP & FSSC 22000 CERTIFIED COMPANY) CIN: L24100MH1972PLC016149 3. Key Managerial Personnel under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the requirement under the Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the following Key Managerial Personnel (KMP’s) of our Company are severally authorized to determine materiality of an event or information and make disclosures to stock exchange(s): Name Designation Mrs. Ramya Bharathram Managing Director & CFO Mr. Aditya Sharma Company Secretary A single point of contact of the KMP’s for the above purpose is as below: Mr. Aditya Sharma Company Secretary Thirumalai Chemicals Limited Spic House, 5th Floor, 88, Mount Road, Guindy, Chennai – 600032, India. Cont.: 044-66057736 E: aditya.s@thirumalaichemicals.com The above information is also being made available on the website of the company at https://thirumalaichemicals.com. The Board meeting commended at 10.45 a.m. and concluded at 2:20 p.m. Kindly take the above information into your records. Thanking you, Yours faithfully, For Thirumalai Chemicals Limited Aditya Sharma Company Secretary & Compliance officer Encl.: As above Annexure –A - Unaudited Financial Results for the quarter/half year ended September 30, 2026 THIRUMALAICHEMICALSLIMITED REGDOFFICE:THIRUMALAIHOUSE,PLOTNO.101/102,SIONMATUNGAESTATE,ROADNO29,SION(EAST),MUMBAI400022 CINL24100MH1972PLC016149 Statementofstandaloneandconsolidatedunauditedfinancialresultsforthequarterandhalfyearended30Septemljer2026 Standalone Consolidated Quarterended Halfyearended Quarterended Halfyearended 30Sep2026 30June2026 30Sep2025 30Sep2026 30Sep2025 30Sep2026 30June2026 30Sep2025 30Sep2026 30Sep2025 Unaudited Unaudited Unaudited Unaudited 1.Income Revenuefromoperations 33,927 33,065 35,701 66,992 80,251 1,35,973 59,647 54,667 44,537 1,14,314 89,542 1,73,552 Otherincome 2,027 976 1,486 3,003 1,796 3,355 971 329 839 1,300 1,871 Totalincome 69,995 82,047 1,39,328 45,376 1,15,614 90,208 1,75.423 2.Expenses Costofmaterialsconsumed 23,461 23,045 23,626 46,506 51,529 80,132 42,595 42,778 38,506 85,373 75,028 Projectmaterialandcontractcosts 346 293 1,163 639 5,357 6,178 Purchaseofstockintrade 822 520 6,019 1,342 12,619 24,885 781 294 56 1,075 87 1,769 Changesininventoriesoffinishedgoods,workinprogressandstockin 427 (1,653) (1,919) (1,226) (2,481) 1,232 1,077 (2,471) (4,413) (1,394) (4,315) 1,493 trade Employeebenefitsexpense 1,259 1,314 1,557 2,573 2,760 5,579 1,868 1,942 2,397 3,810 4,719 8,784 Financecosts 2,673 2,405 2,021 5,078 3,659 7,693 5,666 5,197 2,572 10,863 4,391 8,900 Depreciationandamortisationexpense 764 772 870 1,536 1,730 3,341 2,189 2,299 2,279 4,488 4,443 8,836 Otherexpenses 4,638 5,463 5,602 10,101 10,444 19,309 9,459 8,867 8,356 18,326 16,669 31,524 Totalexpenses 34,390 32,159 38,939 66,549 85,617 1,48,349 63,635 58,906 49,753 1,94,804 3.Profit/(loss)beforetaxandexceptionalItem(1-2) "T564 1,882 (1,752) 3.446 (3.570) (9,021) (3,017) (3.910) (4.377) (6,927) (10,814) (19,381) 4.Exceptionalitem 798 5.Profit/(loss)t>eforetax(3-4) 1,882 (1,752) (3,570) (3,017) (3,910) (4,377) (20,179) 6.Incometaxexpense/(benefit) Currenttax 41 Deferredtax (420) (855) (2,538) 414 (1,039) (1,480) (3,079) Taxrelatedtopreviousyear (387) (350) Totaltaxexpense/(l)enefit) (420) (855) (2.925) (1.039) (1,480) (3,388) 7.ProfitI(loss)fortheperiod/year(5-6) 1,165 1,421 Mm (2,715) (6,540) J3^ (7,798) (16.791) 8.Othercomprehensiveincome: (A)Itemsthatwillbereclassifiedtoprofitorloss -Exchangedifferencesontranslationofforeignoperations 1,979 3,630 1,891 3,605 12,027 -Cashflowhedgereserve (239) (89) (286) (130) (B)Itemsthatwillnotbereclassifiedtoprofitorloss -Re-measurementsofdefinedbenefrtplans (72) (70) (8) (76) (74) 25 -Equityinstrumentsthroughothercomprehensiveincome,net 731 (1.591; 1,610 (225) (4,538) 731 (1,591 (225) (4,538: -Incometaxrelatingtoitemsthatwillnotbereclassifiedtoprofitor (105) 252 249 50 651 (105) 50 651 loss Othercomprehensiveincome/(loss)fortheperiod/year,netoftax (1.411) 1,859 (245) (3,895) 2,973 2.126 3,750 3,070 8,035 Totalcomprehensiveincome/(loss)fortheperiod/year(7+8) 2,398 Mm (2.960) (10,435) J4581 £m Mm (4,048) (6,264) (8,756) Paid-upequitysharecapital 1,206 1,187 1,206 1,206 1,206 1,187 1,206 Otherequity 1,48,574 1,55,154 EarningsI(loss)perequityshare Basic(in?)(Facevalueoff1each)(Notannualised) (1.22) (2.57) (5.81 (2.85) (3.62) (3.07) (647) (884) (14.91 Diluted(inf)(Facevalueof?1each)(Notannualised) (1.22) (2.57) (5.81 (2.85) (3.62) (3.07) (6.47) (8.84) (1491 CHENNAJ Ho.; 600032 Notes: 1 The Audit Committee has reviewed, and the Board of Directors have approved the above results intheir respective meetings held on 04 November 2026 and 05 November 2026. The Statutory Auditorsofthe Company have carried out limitedreviewofthe above said results respectively. 2 InaccordancewithIndAS108,OperatingSegments, theCompany/Grouphasidentifiedmanufactureandsaleoforganicchemicalsastheonly reportablesegment. 3 Thestandaloneand consolidated financialresults have been prepared inaccordancewithrecognitionand measurementprincipleslaiddownin the IndianAccountingStandard 34,Interim FinancialReporting(IndAS34)prescribedunderSection133oftheCompaniesAct2013,theAct and otheraccountingprinciples generallyaccepted inIndiaand is incompliancewith the presentationand disclosure requirementsofthe regulation33oftheSEBI(Listingobligationanddisclosurerequirements)Regulations,2015asamended. 4 TheGrouphasincurredanetlossof?3,431lak [Showing first 8,000 characters — download PDF for full document]